CRIS Current Research Information System

BARBARA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.266
EU - Europa 10.142
AS - Asia 3.624
AF - Africa 564
SA - Sud America 42
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 1
Totale 27.674
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.215
IT - Italia 2.778
GB - Regno Unito 2.694
DE - Germania 1.119
CN - Cina 1.072
VN - Vietnam 1.026
SE - Svezia 967
SG - Singapore 769
UA - Ucraina 646
IN - India 503
IE - Irlanda 405
FR - Francia 343
RU - Federazione Russa 322
CH - Svizzera 238
EE - Estonia 178
ZA - Sudafrica 175
TG - Togo 157
NG - Nigeria 120
JO - Giordania 108
BG - Bulgaria 84
FI - Finlandia 81
AT - Austria 61
CI - Costa d'Avorio 58
SC - Seychelles 44
NL - Olanda 41
BE - Belgio 40
IR - Iran 37
GR - Grecia 35
CA - Canada 34
AU - Australia 28
BR - Brasile 25
JP - Giappone 21
PL - Polonia 20
PT - Portogallo 17
HK - Hong Kong 16
HR - Croazia 16
ES - Italia 14
RO - Romania 14
CZ - Repubblica Ceca 10
LB - Libano 10
KR - Corea 9
MX - Messico 9
TR - Turchia 8
CL - Cile 7
NZ - Nuova Zelanda 7
PH - Filippine 7
UZ - Uzbekistan 7
EG - Egitto 5
ID - Indonesia 5
TW - Taiwan 5
EC - Ecuador 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
CO - Colombia 3
GT - Guatemala 3
YE - Yemen 3
AG - Antigua e Barbuda 2
AR - Argentina 2
DK - Danimarca 2
DZ - Algeria 2
HU - Ungheria 2
IL - Israele 2
LV - Lettonia 2
MT - Malta 2
MY - Malesia 2
PK - Pakistan 2
RS - Serbia 2
SV - El Salvador 2
TH - Thailandia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MK - Macedonia 1
PA - Panama 1
SM - San Marino 1
TZ - Tanzania 1
Totale 27.674
Salva come PNG Salva come JPEG
Città #
Southend 2.422
Houston 2.123
Fairfield 1.471
Ashburn 899
Chandler 842
Dong Ket 680
Woodbridge 674
Singapore 654
Wilmington 629
Seattle 607
Princeton 526
Ann Arbor 471
Cambridge 471
Dublin 400
Jacksonville 382
Bologna 327
Milan 262
Padova 231
Westminster 219
Nanjing 211
Bern 205
Rome 194
Berlin 163
Lomé 157
New York 153
Santa Clara 140
Abeokuta 109
Amman 106
Jinan 106
San Diego 104
Saint Petersburg 100
Shenyang 100
Turin 86
Sofia 81
Beijing 77
Mülheim 77
Bremen 76
Brescia 75
Medford 70
Dearborn 64
Hebei 64
Helsinki 63
Changsha 62
Florence 60
Falls Church 59
Abidjan 58
Nanchang 57
Vienna 48
Des Moines 46
Tianjin 45
Mahé 42
Boardman 39
Guangzhou 39
Jiaxing 38
Washington 36
Brussels 35
Redwood City 34
Olalla 33
Haikou 31
Norwalk 31
Zhengzhou 31
Frankfurt am Main 30
Verona 30
Los Angeles 29
Ningbo 29
Hyderabad 27
Mountain View 27
Naples 24
Redmond 24
Taizhou 23
Hangzhou 22
London 21
Palermo 21
Parma 20
Pune 20
Bari 19
Kunming 19
Toronto 19
Bühl 18
Cagliari 18
Taiyuan 18
Kuban 17
Catania 16
San Francisco 16
Tokyo 15
Costa Mesa 14
Genoa 14
Lappeenranta 14
Lausanne 14
São Paulo 14
Paris 13
Phoenix 13
Pisa 13
Frankfurt Am Main 12
Lanzhou 12
Perugia 12
San Venanzo 12
Ardabil 11
Chicago 11
Leawood 11
Totale 18.407
Salva come PNG Salva come JPEG
Nome #
New pathophysiological mechanisms in irritable bowel syndrome. 1.747
Interazioni tra sistema serotoninergico e mediatori dell'infiammazione nella fisiopatologia della sindrome dell'intestino irritabile 540
Seasonal pattern of peptic ulcer hospitalizations: analysis of the hospital discharge data of the Emilia-Romagna region of Italy. 488
Italian guidelines for the management of irritable bowel syndrome: Joint Consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), General Medicine (SIMG), Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP) and Pediatrics (SIP) 456
Chronic intestinal pseudo-obstruction related to viral infections. 237
Anti-ganglioside antibodies in coeliac disease with neurological disorders. 196
La sindrome dell'intestino irritabile. 195
Abnormalities of somatic peptide-containing nerves supplying the pelvic floor of women with genitourinary prolapse and stress urinary incontinence. 194
Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators 191
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. 190
A novel locus for syndromic chronic idiopathic intestinal pseudo-obstruction maps to chromosome 8q23-q24. 181
Diagnosis and therapy of irritable bowel syndrome 180
Il sistema nervoso enterico. 179
null 179
A-Transducin, a Signaling Molecule of the Chemoreceptive Cascade, Is Expressed in Endocrine and Non-Endocrine Cells of the Pig Gastrointestinal Mucosa 178
Aminosalicylates and other anti-inflammatory compounds for irritable bowel syndrome. 174
Advancements in drug development for diarrhea-predominant irritable bowel syndrome 161
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 160
Chronic intestinal pseudo-obstruction: manifestations, natural history and management. 158
Almost all irritable bowel syndromes are post-infectious and respond to probiotics: controversial issues. 157
5-oxoETE triggers nociception in constipation-predominant irritable bowel syndrome through MAS-related G protein–coupled receptor D 150
Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons 149
Chemosensitività intestinale, nervi, cellule enteroendocrine, recettori del gusto 148
Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. 146
Animal models of chemically induced intestinal inflammation: Predictivity and ethical issues 145
Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome 145
Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis 145
New insights into human enteric neuropathies. 144
Chronic intestinal pseudo-obstruction. 143
CLINICAL AND NEUROCHEMICAL FEATURES OF CHRONIC CONSTIPATION IN PATIENTS WITH PARKINSON DISEASE 143
A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome 142
JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction. 140
Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial 140
beta3-adrenoceptors in the gut: evidence for a possible role in enteric neuroimmunomodulation 139
Chronic intestinal pseudo-obstruction: clinical features, diagnosis, and therapy. 138
5-HT7 Receptors Modulate Peristalsis and Accommodation in the Guinea Pig Ileum 137
A case of paraneoplastic inflammatory neuropathy of the gastrointestinal tract related to an underlying neuroblastoma: successful management with immunosuppressive therapy. 136
A mediator cocktail released from mucosal biopsies of IBS patients excites human and guinea pig enteric neurons. 135
Use of macrogol 4000 in chronic constipation. 134
MALATTIA DA REFLUSSO GASTROESOFAGEO 133
Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome 133
Serine proteases: new players in diarrhoea-predominant irritable bowel syndrome 132
Altered Serotonin Signaling and Extrinsic Sensory Neuron Activation in Irritable Bowel Syndrome 132
Antiflagellin antibodies suggest infective participation in irritable bowel syndrome pathogenesis. 132
Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. 131
Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study. 131
Clinical approach to diarrhea 131
Changes of α-transducin immunoreactivity (IR) in the pig gastrointestinal (GI) mucosa evoked by fasting/refeeding. 131
Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers 130
Aspetti clinici ed anticorpi anti-neurone nella malattia celiaca con disordini neurologici 128
Functional variants in the sucrase-isomaltase gene associate with increased risk of irritable bowel syndrome 127
Paraneoplastic Syndrome 124
Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome 124
Caratterizzazione genetico-molecolare e morfologica di un modello sperimentale di megacolon congenito non agangliare. 124
Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. 123
Expression and regulation of α-transducin in the pig gastrointestinal tract 122
Diagnostic challenges of symptomatic uncomplicated diverticular disease 122
Mutations in RAD21 Disrupt Regulation of APOB in Patients With Chronic Intestinal Pseudo-Obstruction. 121
Sympathetic hyperactivity in patients with ulcerative colitis. 120
Biomarkers in IBS: when will they replace symptoms for diagnosis and management? 120
Sensorineural hearing loss and celiac disease: a coincidental finding 120
Gut microbiota and related diseases: clinical features. 118
Randomised controlled trial of mesalazine in IBS 118
Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism 118
METODO E KIT PER LA DIAGNOSI DELLA SENSIBILITA’ AL GLUTINE NON ASSOCIATA ALLA CELIACHIA 118
Neuroplasticity of the enteric nervous system induced by inflammatory conditions in the gut 117
Sigmoid compliance and visceral perception in spinal cord injury patients 117
Chronic intestinal pseudo-obstruction. 116
X Congresso Nazionale delle Malattie Digestive AIGO-SIED-SIGE. 115
Neuroplasticità gastroenterica: dai geni all’infiammazione. 115
Post-infectious Irritable Bowel Syndrome. 115
Enteric neuropathy evoked by repeated cisplatin in the rat. 115
Pancreatic involvement in systemic sarcoidosis. A case report. 114
Delayed gastric emptying in functional dyspepsia 114
Serum zonulin and its diagnostic performance in non-coeliac gluten sensitivity 114
Role for protease activity in visceral pain in irritable bowel syndrome. 113
Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome 112
Postinfectious Gastroparesis Related to Autonomic Failure: A Case Report 112
The immune system in irritable bowel syndrome. 112
Implications of SARS-CoV-2 infection for neurogastroenterology 112
Interactions between commensal bacteria and gut sensorimotor function in health and disease. 110
Inflammation as a cause of functional bowel disorders. 109
Evidence of RET/GDNF-related apolipoprotein B (APOB) activation and altered expression in patients with chronic intestinal pseudo-obstruction (CIPO) 109
Neuropathological analisys and clinical correlates of chronic constipation in patients with parkinson’s disease 109
Changes of α-transducin immunoreactivity in the pig gastrointestinal (GI) mucosa evoked by fasting/re-feeding 108
null 108
Gastroesophageal reflux disease: clinical and pathophysiological features (part I)] 107
Mucosal barrier defects in irritable bowel syndrome. Who left the door open? 107
Gastro-oesophageal reflux and interstitial lung disease. 107
Inflammatory neuropathies of the enteric nervous system 107
Salmonella gastroenteritis during childhood is a risk factor for irritable bowel syndrome in adulthood 107
Expression of alpha-transducin, a chemoreceptive molecule, in endocrine and non-endocrine cells of the pig gastrointestinal tract 106
A new reliable method for evaluating gallbladder dynamics the 3-dimensional sonographic examination 106
Gastroesophageal reflux disease: therapeutic features (Part II)] 105
Increased Prevalence of Rare Sucrase-isomaltase (SI) Pathogenic Variants in Irritable Bowel Syndrome Patients 105
Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome 105
Malattia da reflusso gastroesofageo. 105
Postinfectious irritable bowel syndrome. 104
Enteric neuroplasticity evoked by inflammation 104
La malattia da reflusso gastroesofageo. 103
Totale 15.947
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.760
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.760
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.926 0 0 325 693 725 692 930 805 754 398 212 392
2020/20213.799 733 261 115 146 122 198 81 237 345 274 178 1.109
2021/20225.375 526 174 269 250 400 276 141 297 189 243 1.840 770
2022/20235.221 498 718 318 601 338 352 173 373 881 197 386 386
2023/20242.583 136 280 190 198 265 492 143 160 104 231 198 186
2024/20251.684 408 1.095 181 0 0 0 0 0 0 0 0 0
Totale 28.384